AMY MIKLOS: Open Payments
NPI 1235501099 · ANSONIA, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 24 payments from 10 companies in 2025. Trend: 2023 $502 · 2024 $1,558 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $146 |
| Ardelyx, Inc. | 3 | $68 |
| Madrigal Pharmaceuticals | 2 | $64 |
| Exact Sciences Corporation | 2 | $59 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| QOL Medical, LLC | 1 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Intra-Sana Laboratories | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: SKYRIZI, IBSRELA, REZDIFFRA, ZENPEP, Sucraid, The Cologuard Plus Collection Kit, Cologuard Collection Kit, ENTYVIO.
Industry payments across CT — which companies pay providers there.
